@greenservices2829: A major milestone in diabetes care. Awiqli® (insulin icodec) is the first FDA-approved once-weekly basal insulin for adults with Type 2 Diabetes, offering an innovative alternative to daily basal insulin injections. This advancement has the potential to simplify treatment routines while maintaining effective glycemic control. #DiabetesCare #Awiqli #InsulinIcodec #Pharmacist #ClinicalPharmacy

Dr Dawood RPH

Open In TikTok:

Region: SA

Saturday 30 May 2026 19:02:57 GMT